971 related articles for article (PubMed ID: 9421921)
1. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU.
Diamond A; Prevor MB; Callender G; Druin DP
Monogr Soc Res Child Dev; 1997; 62(4):i-v, 1-208. PubMed ID: 9421921
[TBL] [Abstract][Full Text] [Related]
2. Evidence for the importance of dopamine for prefrontal cortex functions early in life.
Diamond A
Philos Trans R Soc Lond B Biol Sci; 1996 Oct; 351(1346):1483-93; discussion 1494. PubMed ID: 8941960
[TBL] [Abstract][Full Text] [Related]
3. Age-related working memory impairments in children with prefrontal dysfunction associated with phenylketonuria.
White DA; Nortz MJ; Mandernach T; Huntington K; Steiner RD
J Int Neuropsychol Soc; 2002 Jan; 8(1):1-11. PubMed ID: 11843066
[TBL] [Abstract][Full Text] [Related]
4. Are neuropsychological impairments in children with early-treated phenylketonuria (PKU) related to white matter abnormalities or elevated phenylalanine levels?
Anderson PJ; Wood SJ; Francis DE; Coleman L; Anderson V; Boneh A
Dev Neuropsychol; 2007; 32(2):645-68. PubMed ID: 17931123
[TBL] [Abstract][Full Text] [Related]
5. A preliminary investigation of the role of the phenylalanine:tyrosine ratio in children with early and continuously treated phenylketonuria: toward identification of "safe" levels.
Sharman R; Sullivan K; Young R; McGill J
Dev Neuropsychol; 2010; 35(1):57-65. PubMed ID: 20390592
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of prepotent responding and attentional flexibility in treated phenylketonuria.
Huijbregts S; de Sonneville L; Licht R; Sergeant J; van Spronsen F
Dev Neuropsychol; 2002; 22(2):481-99. PubMed ID: 12537335
[TBL] [Abstract][Full Text] [Related]
7. Neuropsychology of early-treated phenylketonuria: specific executive function deficits.
Welsh MC; Pennington BF; Ozonoff S; Rouse B; McCabe ER
Child Dev; 1990 Dec; 61(6):1697-713. PubMed ID: 2083493
[TBL] [Abstract][Full Text] [Related]
8. A comparison of phenylketonuria with attention deficit hyperactivity disorder: do markedly different aetiologies deliver common phenotypes?
Stevenson M; McNaughton N
Brain Res Bull; 2013 Oct; 99():63-83. PubMed ID: 24140048
[TBL] [Abstract][Full Text] [Related]
9. Biochemical markers associated with executive function in adolescents with early and continuously treated phenylketonuria.
Sharman R; Sullivan K; Young R; McGill J
Clin Genet; 2009 Feb; 75(2):169-74. PubMed ID: 19215250
[TBL] [Abstract][Full Text] [Related]
10. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study.
Jahja R; Huijbregts SC; de Sonneville LM; van der Meere JJ; Bosch AM; Hollak CE; Rubio-Gozalbo ME; Brouwers MC; Hofstede FC; de Vries MC; Janssen MC; van der Ploeg AT; Langendonk JG; van Spronsen FJ
Mol Genet Metab; 2013; 110 Suppl():S57-61. PubMed ID: 24183792
[TBL] [Abstract][Full Text] [Related]
11. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study.
Schindeler S; Ghosh-Jerath S; Thompson S; Rocca A; Joy P; Kemp A; Rae C; Green K; Wilcken B; Christodoulou J
Mol Genet Metab; 2007 May; 91(1):48-54. PubMed ID: 17368065
[TBL] [Abstract][Full Text] [Related]
12. Executive functioning, memory, and learning in phenylketonuria.
Channon S; German E; Cassina C; Lee P
Neuropsychology; 2004 Oct; 18(4):613-20. PubMed ID: 15506828
[TBL] [Abstract][Full Text] [Related]
13. A preliminary report on dopamine system reactivity in PKU: acute effects of haloperidol on neuropsychological, physiological, and neuroendocrine functions.
Luciana M; Hanson KL; Whitley CB
Psychopharmacology (Berl); 2004 Aug; 175(1):18-25. PubMed ID: 15024549
[TBL] [Abstract][Full Text] [Related]
14. Executive functioning in children and adolescents with phenylketonuria.
VanZutphen K; Packman W; Sporri L; Needham M; Morgan C; Weisiger K; Packman S
Clin Genet; 2007 Jul; 72(1):13-8. PubMed ID: 17594394
[TBL] [Abstract][Full Text] [Related]
15. Stability of blood phenylalanine levels and IQ in children with phenylketonuria.
Anastasoaie V; Kurzius L; Forbes P; Waisbren S
Mol Genet Metab; 2008; 95(1-2):17-20. PubMed ID: 18703366
[TBL] [Abstract][Full Text] [Related]
16. Intellectual, neurologic, and neuropsychologic outcome in untreated subjects with nonphenylketonuria hyperphenylalaninemia. German Collaborative Study on Phenylketonuria.
Weglage J; Ullrich K; Pietsch M; Fünders B; Güttler F; Harms E
Pediatr Res; 1997 Sep; 42(3):378-84. PubMed ID: 9284280
[TBL] [Abstract][Full Text] [Related]
17. Impact of the phenylalanine hydroxylase gene on maternal phenylketonuria outcome.
Güttler F; Azen C; Guldberg P; Romstad A; Hanley WB; Levy HL; Matalon R; Rouse BM; Trefz F; de la Cruz F; Koch R
Pediatrics; 2003 Dec; 112(6 Pt 2):1530-3. PubMed ID: 14654659
[TBL] [Abstract][Full Text] [Related]
18. [Structural and functional neuroanatomy of attention-deficit hyperactivity disorder (ADHD)].
Emond V; Joyal C; Poissant H
Encephale; 2009 Apr; 35(2):107-14. PubMed ID: 19393378
[TBL] [Abstract][Full Text] [Related]
19. Sustained attention in adult phenylketonuria: the influence of the concurrent phenylalanine-blood-level.
Schmidt E; Rupp A; Burgard P; Pietz J; Weglage J; de Sonneville L
J Clin Exp Neuropsychol; 1994 Oct; 16(5):681-8. PubMed ID: 7836491
[TBL] [Abstract][Full Text] [Related]
20. Associations between phenylalanine-to-tyrosine ratios and performance on tests of neuropsychological function in adolescents treated early and continuously for phenylketonuria.
Luciana M; Sullivan J; Nelson CA
Child Dev; 2001; 72(6):1637-52. PubMed ID: 11768137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
